SILODOSIN (silodosin) by Hetero is adrenergic alpha-antagonists [moa]. Approved for the signs, symptoms of benign prostatic hyperplasia (bph) [see clinical studies ( )], hypertension and 1 more indications. First approved in 2018.
Drug data last refreshed 21h ago
Adrenergic alpha-Antagonists
alpha-Adrenergic Blocker
Worked on SILODOSIN at Hetero? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia
Efficacy and Safety of Silodosin in the Treatment of Natural Expulsion in Patients With Ureteral Stones
Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia
Efficacy and Safety of Silodosin on Voiding Dysfunction Associated With Neurogenic Bladder
Study of a α1A Adrenoceptor Selective Antagonist Silodosin to Treat Severe Benign Prostatic Hyperplasia(BPH)